电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant HLA-ABC 抗体

This 小鼠 单克隆 anti-HLA-ABC antibody (Clone W6-32) specifically detects HLA-ABC in ELISA, Func, IGA 和 Neut. The antibody is reactive with 人 samples.
产品编号 ABIN7795424
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant HLA-ABC 抗体 (ABIN7795424)

抗原

See all HLA-ABC 抗体
HLA-ABC

抗体类型

Recombinant Antibody

适用

  • 77
  • 28
  • 19
  • 17
  • 15
  • 13
  • 13
  • 12
  • 12
  • 11
  • 7
  • 7
  • 6
  • 6
  • 2
  • 1

宿主

  • 62
  • 10
  • 4
  • 1
小鼠

克隆类型

  • 67
  • 9
单克隆

标记

  • 31
  • 7
  • 7
  • 7
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HLA-ABC antibody is un-conjugated

应用范围

  • 60
  • 18
  • 17
  • 13
  • 10
  • 10
  • 9
  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Functional Studies (Func), Immunogenicity Assay (IGA), Neutralization (Neut)

质量等级

In vivo Grade

克隆位点

W6-32
  • Expression System

    Mammalian cells

    原理

    In vivo Grade Recombinant Anti-Human HLA-ABC Monoclonal Antibody, Mouse IgG2a Kappa (Clone: W6/32)

    产品特性

    The in vivo grade recombinant anti-human HLA-ABC Mouse IgG2a Kappa monoclonal antibody was produced in mammalian cells.

    纯化方法

    Protein A or G affinity column

    纯度

    >95 % by reducing SDS-PAGE

    内毒素水平

    < 1 EU per 1 mg of the protein by the LAL method

    亚型

    IgG2a
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    > 3 mg/mL

    储存条件

    4 °C,-20 °C

    储存方法

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • 抗原

    HLA-ABC

    别名

    HLA-ABC

    途径

    TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here: